NON-NEUROGENIC VOIDING DYSFUNCTION 567
Investigations
Obtain urinalysis (infection, protein, glucose) and voiding diary and assess flow rate.
In selected cases, US of the renal tract (hydronephrosis, bladder size); VCUG (VUR, post-void residual), videourodynamics (over or underactive detrusor, sphincter dyssynergia), or MRI of the spine (if clinical suspicion of neurological cause) is indicated.
Management
This includes behavioral therapy (bladder retraining, timed voiding, change of voiding posture, psychological support); medication (antibiotics for infection, anticholinergics for bladder overactivity and urgency, laxatives or enemas for constipation); and intermittent catheterization to drain post-void residuals. Surgery is rarely indicated.
Prognosis
Fifteen percent of cases spontaneously resolve per year.
568 CHAPTER 15 Pediatric urology
Enuresis is normal but involuntary voiding that occurs at an inappropriate time or social setting, during the day, night, or both. Nocturnal enuresis describes any involuntary loss of urine during sleep.
Prevalence
Approximately 750,000 children over age 7 years will regularly wet the bed. The prevalence in adults is ~0.5%.
Prevalence
Age (years) |
Females |
Males |
5 |
10–15% |
15–20% |
7 |
7–15% |
15–20% |
9 |
5–10% |
10–15% |
16 |
1–2% |
1–2% |
|
|
|
Classification
•Primary: never been dry for more than a 6-month period
•Secondary: re-emergence of bed wetting after a period of being dry for at least 6 months
Etiology
•Familial
•Delay in functional bladder maturation
•Altered antidiuretic hormone (ADH) secretion; abnormal decrease in ADH levels at night causes increased urine production (nocturnal polyuria)
•Altered sleep/arousal mechanism
•Psychological factors
•UTI (1% of cases)
Evaluation
•History: frequency of episodes; daytime symptoms; new or recurrent; family history; UTIs; bowel problems; psychosocial history
•Examination: exclude organic causes (neurological disease)
•Investigation: urinalysis (infection, specific gravity is reduced in nocturnal polyuria, glucose, protein); voiding diary
Management
Behavioral
Provide reassurance; bladder training; motivational techniques to improve the child’s self-esteem; conditioning therapy (an alarm is connected to the child’s underwear, which is triggered with the first few drops of urine).
NOCTURNAL ENURESIS 569
Pharmacological
•Imipramine—a tricyclic antidepressant with anticholinergic, antispasmodic properties.
•DDAVP or desmopressin (synthetic analogue of ADH) given intranasally or orally
Prognosis
Fifteen percent of patients have spontaneous resolution of symptoms per year.
This page intentionally left blank
Chapter 16 |
571 |
|
|
Preparation of the patient for urological surgery 572 Antibiotic prophylaxis in urological surgery 574 Complications of surgery in general: DVT and PE 576 Fluid balance and management of shock in the surgical
patient 580
Patient safety in the operating room 582 Transurethral resection (TUR) syndrome 583 Catheters and drains in urological surgery 584 Guide wires 590
Irrigating fluids and techniques of bladder washout 592 JJ stents 594
Lasers in urological surgery 598 Diathermy 600
Sterilization of urological equipment 604
Telescopes and light sources in urological endoscopy 606 Consent: general principles 608
Cystoscopy 610
Transurethral resection of the prostate (TURP) 612 Transurethral resection of bladder tumor (TURBT) 614 Optical urethrotomy 616
Circumcision 618
Hydrocele and epididymal cyst removal 620 Nesbit procedure 622
Vasectomy and vasovasostomy 624 Orchiectomy 626
Urological incisions 628 JJ stent insertion 630
Nephrectomy and nephroureterectomy 632 Radical prostatectomy 634
Radical cystectomy 636 Ileal conduit 640
Percutaneous nephrolithotomy (PCNL) 642 Ureteroscopes and ureteroscopy 646 Pyeloplasty 650
Laparoscopic surgery 652
Endoscopic cystolitholapaxy and (open) cystolithotomy 654 Scrotal exploration for torsion and orchiopexy 656